Clinical trial
Safety and Efficacy of RC-1291 HCl in Patients With Cancer Related Anorexia and…
NCT00219817 · Helsinn Therapeutics (U.S.), Inc, Industry · Completed
Key facts
| NCT number | NCT00219817 |
|---|---|
| Title | Safety and Efficacy of RC-1291 HCl in Patients With Cancer Related Anorexia and Weight Loss |
| Lead sponsor | Helsinn Therapeutics (U.S.), Inc, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cancer Cachexia |
| Intervention type | Drug |
| Interventions | RC-1291 HCl |
| Enrollment | 80 |
| Start date | Jun 1, 2005 |
| Primary completion | Oct 1, 2006 |
| Completion | Oct 1, 2006 |
| First posted | Sep 22, 2005 |
| Last update posted | Sep 2, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: